Figure 5
Learning the matrix of the final saccades that preceded CS presentation. (a) Schematic illustration of a final saccade capturing the HA and its parameters. (b) and (c) Vectors of final saccades when the CS was presented in the lesion-affected field. The final saccades of the 20 successful trials among the trial No. 1–34 (b) and trial No. 80–99 (c) of a session which is the first session in Fig. 4a, b. A final saccade was characterized by three parameters [start point (d), direction (e) and amplitude (f)] of the vector from its onset location to its offset in the HA (a). (d)–(f) Saccade parameters in a session, shown in (b) and (c). Start point (d), direction (e) and amplitude (f) of the final saccades. (g) and (h) Distribution of variance of direction of the final saccades in multiple sessions. (g) CS in the intact field and (h) lesion-affected field.
